Scott M Whitcup has an estimated net worth of $26.6 Million. This is based on reported shares across multiple companies, which include Nightstar Therapeutics plc, Menlo Therapeutics Inc., Adverum Biotechnologies, Inc., ALLERGAN INC, QUESTCOR PHARMACEUTICALS INC, and AVANIR PHARMACEUTICALS, INC..
2013 was Scott M Whitcup's most active year for acquiring shares with 15 total transactions. Scott M Whitcup's most active month to acquire stocks was the month of January. 2013 was Scott M Whitcup's most active year for disposing of shares, totalling 24 transactions. Scott M Whitcup's most active month to dispose stocks was the month of November. 2014 saw Scott M Whitcup paying a total of $12,932,722.05 for 167,015 shares, this is the most they've acquired in one year. In 2014 Scott M Whitcup cashed out on 247,403 shares for a total of $12,468,137.88, their largest year based on trade value.